Clinical Pharmacokinetics

, Volume 3, Issue 4, pp 313–318 | Cite as

Migraine and Drug Absorption

  • G. N. Volans
Research Review

Summary

The majority of migraine attacks are associated with gastrointestinal symptoms which add considerably to the distress and inconvenience caused by the headache. When salicylate absorption from effervescent aspirin tablets was studied during migraine, the rate of absorption was found to be reduced relative to that found in non-migrainous volunteers and in the same patients when headache-free. There is evidence that this reduced rate of absorption is caused by gastrointestinal stasis and reduced rate of gastric emptying. Patients in whom aspirin absorption was delayed were more likely to take longer to respond and to require additional treatment. Metoclopramide, which increases gastric emptying rate, has been shown to improve the rate of absorption of aspirin during migraine and also increase the rate of recovery from the attack and avoid the need for additional treatment; effects which were not shown by thiethylperazine.

It is likely that delayed absorption during migraine affects some drugs other than aspirin, such as ergotamine, and it is therefore recommended that the most rapidly absorbable formulation should be used. If such treatment is ineffective, metoclopramide may be a useful addition and should be tried before resorting to other routes of administration.

Keywords

Migraine Aspirin Gastric Emptying Metoclopramide Migraine Attack 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams, F.: Edited translation of ‘The extant works of Areteus the Cappadocian’ pp. 294–296 (Wertheimer, London 1856).Google Scholar
  2. Carstairs, L.S.: Headache and gastric emptying time. Proceedings of the Royal Society of Medicine 51: 790–791 (1958).PubMedGoogle Scholar
  3. Heading, R.C.; Nimmo, J.; Prescott, L.F. and Tothill, P.: The dependence of paracetamol absorption on the rate of gastric emptying. British Journal of Pharmacology 47: 415–421 (1973).PubMedCrossRefGoogle Scholar
  4. Hurst, A.F. and Stewart, M.J.: Gastric and Duodenal Ulcer p. 233 (Oxford University Press, London 1929).Google Scholar
  5. Kaufman, J. and Levine, I.: Acute gastric dilatation of stomach during attack of migraine. Radiology 27: 301–302 (1936).Google Scholar
  6. Kreel, L.: The-use of metoclopramide in radiology. Postgraduate Medical Journal 49 (Suppl.): 42–45 (July 1973).PubMedGoogle Scholar
  7. Lance, J.W. and Anthony, M.: Some clinical aspects of migraine. Archives of Neurology 15: 356–361 (1966).PubMedCrossRefGoogle Scholar
  8. Martin, B.K.: The absorption and distribution of salicylates; in Binns (Ed) Absorption and Distribution of Drugs, pp. 165–172 (Livingstone, London 1964).Google Scholar
  9. Meier, J. and Schreier, E.: Human plasma levels of some antimigraine drugs. Headache 16: 96–104 (1976).PubMedCrossRefGoogle Scholar
  10. Nimmo, W.S.: Drugs, diseases and altered gastric emptying. Clinical Pharmacokinetics 1: 189–203 (1976).PubMedCrossRefGoogle Scholar
  11. Nimmo, J.; Heading, R.C.; Tothill, P. and Prescott, L.F.: Pharmacological modification of gastric emptying: Effects of propantheline and metoclopramide on paracetamol absorption. British Medical Journal 1: 587–589 (1973).PubMedCrossRefGoogle Scholar
  12. Orton, D.: Ergotamine tartrate levels in migraine, ergotamine tartrate overdose and normal subjects using a radioimmunoassay; in Proceedings of the Migraine Trust International Symposium 16th and 17th September 1976 (Migraine Trust, London 1976).Google Scholar
  13. Reigelman, S.: Physiological and pharmacokinetic complexities in bioavailability testing. Pharmacology 8: 118–141 (1972).CrossRefGoogle Scholar
  14. Sacks, O.W.: Migraine: Evolution of a common disorder (Faber and Faber, London 1970).Google Scholar
  15. Schmidt, R. and Fanchamps, A.: Effect of caffeine on intestinal absorption of ergotamine by man. European Journal of Clinical Pharmacology 7: 213–216 (1974).PubMedCrossRefGoogle Scholar
  16. Slettnes, O. and Sjaastad, O.: Metoclopramide, during attacks of migraine; in Headache: New Vistas, pp. 201–204 (Biomedical Press, Florence 1977).Google Scholar
  17. Smythe, D.H.: Alimentary absorption of drugs: Physiological considerations; in Binns (Ed) Absorption and Distributions of Drugs, pp.1–15 (Livingstone, London 1964).Google Scholar
  18. Volans, G.N.: The effects of food and exercise on the absorptions of effervescent aspirin. British Journal of Clinical Pharmacology 1: 137–141 (1974a).PubMedCrossRefGoogle Scholar
  19. Volans, G.N.: Absorption of effervescent aspirin during migraine. British Medical Journal 4: 265–268 (1974b).PubMedCrossRefGoogle Scholar
  20. Volans, G.N.: The effect of metoclopramide on the absorption of effervescent aspirin in migraine. British Journal of Clinical Pharmacology 2: 57–63 (1975).PubMedGoogle Scholar
  21. Volans, G.N.: The treatment of migraine; in Turner (Ed) Advanced Medicine. Topics in Therapeutics. Vol. 2, pp. 156–172 (Pitman Medical, London 1976).Google Scholar
  22. Wainscott, G.; Kaspi, T. and Volans, G.N.: The influence of thiethylperazine on the absorption of effervescent aspirin in migraine. British Journal of Clinical Pharmacology 3: 1015–1021 (1976).PubMedCrossRefGoogle Scholar
  23. Wilkinson, M.; Wainscott, G.; Ide, J.; Volans, G.N. and Wall, M.C.: An analysis of acute attacks of headache in 1000 patients; in Background to Migraine. Abstracts of the Sixth Migraine Symposium (Migraine Trust, London 1974).Google Scholar

Copyright information

© ADIS Press 1978

Authors and Affiliations

  • G. N. Volans
    • 1
  1. 1.Guy’s HospitalLondonUK

Personalised recommendations